[Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
Bifunctional chelates containing chemical spacer, succinimido-EGS-DTPA (EGS-DTPA, diester spacer) and 1-[4-(10-maleimidopropyl)amidobenzyl]ethylenediamine-N,N,N', N'- tetraacetic acid (C10-Bz-EDTA, hydrocarbon spacer) were synthesized and compared in vitro with non-spacer chelates, cyclic DTPA dianhydride (cDTPAA) and isothiocyanatobenzyl-EDTA (SCN-Bz-EDTA). The optimum condition for conjugation with chelates, labeling efficiency, immunoreactivity and stability in the serum were investigated with respect to four chelates. The labeling efficiency for EGS-DTPA-A7 and DTPA-A7 was 90% and over 95%, respectively, when reacted by the chelate to antibody ratios of 10:1 for EGS-DTPA and 2:1 for cDTPAA. The labeling efficiency for SCN-Bz-EDTA and C10-Bz-EDTA was 70% and 80%, respectively, when both of the chelates were conjugated with the antibody in a 1:1 ratio. EGS-DTPA-A7 and DTPA-A7 were unstable when incubated in the human serum at 37 degrees C and showed the transchelation to the transferrin fraction of the 111In activity. Furthermore, the radioactivity from 111In-EGS-DTPA-A7 was also found to be associated with the In-DTPA fraction, indicating that the diester spacer was cleaved in the serum. SCN-Bz-EDTA-A7 and C10-Bz-EDTA-A7 were very stable: there was no evidence of transchelation or any activity was dissociated from the conjugated antibody when incubated in the human serum for 168 hrs. Using C10-Bz-EDTA, immunoconjugate with sufficient specific activity was obtained and high immunoreactivity was maintained. It was considerable that the C10-Bz-EDTA immunoconjugate would produce preferable biodistribution than EGS-DTPA immunoconjugate do.
Sun
B
B
Department of Nuclear Medicine, Kanazawa University School of Medicine.
D000911:Antibodies, Monoclonal / Q000276:immunology; D002614:Chelating Agents; D004355:Drug Stability; D004492:Edetic Acid; D006801:Humans; D007205:Indium Radioisotopes / Q000276:immunology; D007553:Isotope Labeling / Q000379:methods*; D004369:Pentetic Acid
D000911:Antibodies, Monoclonal; D002614:Chelating Agents; D007205:Indium Radioisotopes; D004369:Pentetic Acid; D004492:Edetic Acid